DEFA14A ·Filed Apr 8, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 2/10
Horizonmonths Processed5mo ago SEC0001193125-26-147718
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard, non-material filing. No immediate trading action is warranted. The board's opposition to the shareholder proposals suggests a conservative stance on ESG initiatives, which may be a point of discussion for long-term investors.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
MRK ▲ +3.40% at T+60d
NEUTRAL call ✓ call won +3.40% · α vs SPY -7.10% · entry $122.62 → $126.78
Entry anchored
Apr 8, 03:59 PM ET
via exchange tick
T+1d
-0.98%
call -0.98% · α -0.91%
$121.42
settled 6mo ago
T+5d
-5.86%
call -5.86% · α -9.05%
$115.43
settled 6mo ago
T+20d
-7.39%
call -7.39% · α -14.95%
$113.56
settled 5mo ago
T+60d
+3.40%
call +3.40% · α -7.10%
$126.78
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Merck's 2026 proxy statement is a routine filing for the annual shareholder meeting, proposing the election of 13 directors, an advisory vote on executive compensation, and the ratification of auditors. It also includes four shareholder proposals on ESG topics, all of which the board recommends voting against. This is standard corporate governance and does not signal any material change in the company's operations or strategy.

Key Facts

  • Routine proxy statement for the 2026 annual meeting.
  • Board recommends voting FOR the election of all 13 director nominees.
  • Board recommends voting FOR the advisory approval of executive compensation.
  • Board recommends voting FOR the ratification of the independent auditor.
  • Board recommends voting AGAINST four shareholder proposals on DEI risks, healthcare coverage gaps, and political contributions.

Financial Impact

No direct financial impact.

Risk Factors

  • Shareholder proposals on ESG topics could lead to future engagement or voting campaigns if support is significant.
  • Board's stance against ESG proposals may face criticism from some investor groups.

Market Snapshot

Price
$123.19
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
69% bullish (35 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-147718
Document: 0001193125-26-147718-index-headers.html0001193125-26-147718
Document: 0001193125-26-147718-index.html0001193125-26-147718
Document: 0001193125-26-147718.txt0001193125-26-147718
20 reports for MRK
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +18.67%Aug 6, 2026
Filters
Rows
Reports for MRK — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Court Ruling
NEUTRAL ★ 1/10
$143.93 $146.87▲ +2.04%▲ +2.26%$144.30 (+0.26%)
Sep 9, 2026
23d ago
Court Ruling
NEUTRAL ★ 1/10
$147.53 $144.91▼ −1.78%▼ −1.12%$144.30 (−2.19%)
Aug 27, 2026
5w ago
Court Ruling
NEUTRAL ★ 1/10
$149.54 $152.34▲ +1.87%▲ +1.60%$144.30 (−3.50%)
Aug 24, 2026
5w ago
Court Ruling
BEARISH ★ 5/10
$150.66 $147.73▲ +1.95%▲ +2.42%$144.30 (+4.22%)
Aug 20, 2026
6w ago
ANALYST-UPGRADE
MIXED ★ 5/10
$148.99 $149.54▲ +0.37%▼ −0.75%$144.30 (−3.15%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.84 $152.55▲ +12.30%▲ +13.67%$144.30 (+6.23%)
Aug 13, 2026
7w ago
Court Ruling
NEUTRAL ★ 3/10
$135.55 $148.99▲ +9.92%▲ +11.88%$144.30 (+6.46%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.55 $148.99▲ +9.92%▲ +11.88%$144.30 (+6.46%)
Aug 12, 2026
7w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$132.92 $152.20▲ +14.51%▲ +14.95%$144.30 (+8.56%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$132.92 $152.20▲ +14.51%▲ +14.95%$144.30 (+8.56%)
Showing 10 of 20

US Market Status

Market Closed — Opens Mon (64h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access